Details for Patent: 8,148,401
✉ Email this page to a colleague
Which drugs does patent 8,148,401 protect, and when does it expire?
Patent 8,148,401 protects DAURISMO and is included in one NDA.
This patent has fifty-eight patent family members in forty-seven countries.
Summary for Patent: 8,148,401
Title: | Benzimidazole derivatives |
Abstract: | The present invention relates to a compound of the Formula I ##STR00001## or a pharmaceutically acceptable salt thereof, wherein R.sup.1, R.sup.2, R.sup.3A, R.sup.3B, R.sup.4, R.sup.5, X, m, and n are as defined herein. Such novel benzamidazole derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds. |
Inventor(s): | Munchhof; Michael J. (Salem, CT), Reiter; Lawrence A. (Mystic, CT), La Greca; Susan D. (Old Lyme, CT), Jones; Christopher S. (Gales Ferry, CT), Li; Qifang (Stonington, CT) |
Assignee: | Pfizer Inc. (New York, NY) |
Application Number: | 12/142,119 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,148,401
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | DAURISMO | glasdegib maleate | TABLET;ORAL | 210656-001 | Nov 21, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
Pfizer | DAURISMO | glasdegib maleate | TABLET;ORAL | 210656-002 | Nov 21, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,148,401
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
African Regional IP Organization (ARIPO) | 2377 | ⤷ Try a Trial | |||
Argentina | 067346 | ⤷ Try a Trial | |||
Argentina | 103632 | ⤷ Try a Trial | |||
Australia | 2008272641 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |